This SOP establishes the requirements for selecting components used in sterile compounding—including verification of APIs through USP–NF monographs, certificates of analysis, and FDA-registered sources; exclusion of withdrawn or unsafe drugs; adherence to FDA guidance on biologics; and qualification of excipients and container systems—to ensure ingredient quality, patient safety, and compliance with USP <797> and FDA regulations.